Page 2 - try
P. 2
TIME
8:00 9:00 - 9:05 9:05 - 9:10 9:10 - 9:15
9:15 - 9:30 9:30 - 9:40
9:40 - 10:10
10:10 - 10:30
Session Speaker
Registration
Welcome ...................................................................................................................... SASLT EASL Word ...................................................................................................................... EASL Program Highlights ...................................................................................... Program Director
Explore NASH Challenges ................................................... chairperson Dr. Sven Franque NASH Burden in Saudi ................................................................................. Dr. Khalid Alswat NASH Case Presentation .................................................................. Dr. Abdulrahman Aljumah
Multidisciplinary Discussion: NASH.. Approach chairperson Dr. Abdulrahman Aljumah Role of Life Style Modification ................................................................. Dr. Adnan Alzanbagi Role of Bariatric Surgery .............................................................................. Dr. Adel Al Qutub Cardiologist Perspective ......................................................................... Dr. Hamed Alghamdi Diabetologist Perspective ...................................................................... Dr. Mourad Al Mourad Management Update ..................................................................... Dr. Sven Franque (Belgium)
Agenda
10:30 - 10:45 10:45 - 11:15
11:15 - 11:35 11:35 -11:55 11:55 -12:10
12:10 - 12:30 12:30 - 12:50 12:50 - 13:35 13:35 - 13:55 13:55 - 14:15
HBV Shaping Tomorrow
HBV Debate .................................................................................... chairperson Dr. Faisal Sanai
HBV Burden and Challenges ............................................................................ Dr. Faisal Sanai
Eligibility Criteria for Treatment ....................................... Dr. George Papatheodoridis (Greece) Guidelines vs. Practices & Dr. Faisal Aba-Alkhail
HCV: Reality & Expectations Towards Elimination ................. chairperson Dr. Faleh Al Faleh HCV: What’s after DDAs - Remaining Challenges .................................. Dr. Xavier Forns (Spain) HCV Elimination: Thinking Forward ............................................................. Dr. Ibrahim Al Traif Break
HCC State of The Art ......................................................... chairperson Dr. Mohamed Babatin Case Study .................................................................................... Dr. Massimo Colombo (Italy) EASL Guidelines Update ......................................................................... Dr. Massimo Colombo Best of EASL 2018 - I’d like to share ............................................................... EASL - ILF Faculty Panel Discussion & Closing Remarks ............................................................ Program Director
Takeaways & Q/A
